(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 1.95% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.92%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.98%.
Baxter International's revenue in 2026 is $11,320,000,000.On average, 18 Wall Street analysts forecast BAX's revenue for 2026 to be $5,922,350,114,736, with the lowest BAX revenue forecast at $5,711,114,290,464, and the highest BAX revenue forecast at $6,220,869,201,360. On average, 18 Wall Street analysts forecast BAX's revenue for 2027 to be $6,044,236,800,624, with the lowest BAX revenue forecast at $5,790,134,048,688, and the highest BAX revenue forecast at $6,390,271,035,984.
In 2028, BAX is forecast to generate $6,204,858,662,112 in revenue, with the lowest revenue forecast at $5,961,085,290,336 and the highest revenue forecast at $6,572,068,126,800.